Wednesday, December 03, 2008
Life Science Network:
Chemie.DE
Bionity.COM
ChemEurope.COM
ChemieKarriere.NET
BioKarriere.NET
Current News
RSS
Search for:
in:
All
Antibodies
Articles
Catalogues
Companies
Events
Life Science Encyclopedia
Market overviews
News
Product presentations
Software
Search
Target:
Full text
Title
Company name
Division:
All
Business
Career
Cooperation
Finances
Laws
Manufacturing
Market
People
Politics
Price Development
Products
Research
Technology
Country:
All
Germany
Austria
Switzerland
U.S.A.
United Kingdom
France
Argentina
Australia
Belgium
Brazil
Canada
China
Cuba
Czech Republic
Denmark
Egypt
Estonia
Ethiopia
Finland
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Ireland
Israel
Italy
Japan
Jordan
Kenya
Lebanon
Liechtenstein
Lithuania
Luxembourg
Malaysia
Mexico
Moldova
Netherlands
New Zealand
Niue
Norway
Peru
Philippines
Poland
Portugal
Puerto Rico
Russia
Rwanda
Singapore
Slovakia
South Africa
South Korea
Spain
Sweden
Taiwan
Thailand
Turkey
Uganda
Ukraine
United Arab Emirates
Viet Nam
Zambia
From:
To:
Operation:
OR
AND
Search for:
partial
exact
Overview
Companies
Countries
Top News
Tag Clouds
People
Politics
Products
Research
Technology
All
Business
Career
Cooperation
Finances
Laws
Manufacturing
Market
Article
1 to 5
out of
5
for
"Ranibizumab"
Ordered by
relevance
alphabet
date
Monoclonal antibody sales to almost double in coming years
(02 Sep 2008)
’s golimumab, Genentech/Novartis’s Lucentis (
ranibizumab
), Roche/Chugai’s Actemra...
more information
Pieris validates the use of Anticalins as ophthalmologic biotherapeutics
(07 Sep 2007)
Lucentis® (
ranibizumab
; Genentech / Novartis). "These exciting results have...
more information
Genentech to set up Singapore's first Microbial-Based Biopharmaceutical Manufacturing Facility
(29 Mar 2007)
Fourth Biologics Facility in Less Than 2 Years Helps Establish Singapore as a Serious Player in Biologics Manufacturing
, is intended for the manufacture of bulk LUCENTIS® (
ranibizumab
injection...
more information
The Crowded Field of VEGF and VEGF-R Targeting Drugs
(18 Aug 2006)
fragment
ranibizumab
. Although sales of pegaptanib suffer from off-label use...
more information
XOMA Licenses BCE Technology for Recombinant Protein Production to Wyeth
(12 Sep 2005)
and Crohn's Disease, and Genentech Inc.'s LucentisTM (
ranibizumab
) antibody fragment...
more information
Additional information matching your search term
Additional information was found matching your search for
"Ranibizumab"
.
Life Science Encyclopedia (4)
more
My
Bionity.COM
User:
Password:
Companies & Products
Buyer's Guide
Product Gallery
Catalogues
Software
Biotech Books
Antibodies
Market Overview
News Center
Current News
Newsletter
Articles
Special Topics
Chromatography
Spectroscopy
NEW!
RSS-Feeds
Information Retrieval
Life Science Encyclopedia
Biotech Search Engine
Job & Career
Events
Toolbox
Specialised Dictionaries
Unit Conversion
Molecular Mass Calculator
Newsletter Subscription
Your e-mail:
Go
About Bionity.COM
The Company
Products & Solutions
Advertising opportunities
Press
Jobs and Careers
Advertising rates
References
Contact
Imprint
Data protection policy
Top
© 2001-2008 Chemie.DE Information Service GmbH
a Life Science Network Division
www.Chemie.DE
www.Bionity.COM
www.ChemEurope.COM
www.ChemieKarriere.NET
www.BioKarriere.NET